A further ANDA patent infringement lawsuit against Teva based on patents no. 10,682,376, no. 10,695,367 and no 11,013,761, all expiring in May 2029 remains pending. 「CSL Vifor welcomes the d…
VFMCRP announces U.S. Court upholds validity of Velphoro® patent
A further ANDA patent infringement lawsuit against Teva based on patents no. 10,682,376, no. 10,695,367 and no 11,013,761, all expiring in May 2029 remains pending. 「CSL Vifor welcomes the d…